Loading...
Time from inclusion to progression documented by imaging and based on RECIST 1.1 and iRECIST criteria or patient death. The iRECIST criteria use the same methods of monitoring tumor lesions as the RECIST 1.1 criteria but a confirmation 4-6 weeks after suspicion of progression is required to confirm or rule out progression because patients undergoing immunotherapy may present pseudo-progressions.
Observation of a partial or complete response according to RECIST 1.1 criteria during the follow-up
Time between the observation of an objective response (partial or complete according to RECIST 1.1 criteria) and the progression